

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.08683281 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.08683281 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.76224560 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.76224560 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.54297757 |
| 6 | complement activation, alternative pathway (GO:0006957) | 5.53732655 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.50203064 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 5.28591090 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.24130043 |
| 10 | regulation of protein activation cascade (GO:2000257) | 5.23172944 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.16624555 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.16061482 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.16061482 |
| 14 | tryptophan catabolic process (GO:0006569) | 5.16061482 |
| 15 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.14074147 |
| 16 | protein carboxylation (GO:0018214) | 5.14074147 |
| 17 | response to peptidoglycan (GO:0032494) | 5.12799057 |
| 18 | urea metabolic process (GO:0019627) | 5.06692002 |
| 19 | urea cycle (GO:0000050) | 5.06692002 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 4.97378299 |
| 21 | regulation of complement activation (GO:0030449) | 4.96601767 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 4.96012206 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86074707 |
| 24 | tryptophan metabolic process (GO:0006568) | 4.82580958 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 4.79859122 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 4.78548840 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 4.73283069 |
| 28 | regulation of fibrinolysis (GO:0051917) | 4.72765811 |
| 29 | glyoxylate metabolic process (GO:0046487) | 4.68984758 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 4.65204987 |
| 31 | cysteine metabolic process (GO:0006534) | 4.63138867 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.60189234 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.43617216 |
| 34 | bile acid metabolic process (GO:0008206) | 4.42707384 |
| 35 | phospholipid efflux (GO:0033700) | 4.35247595 |
| 36 | triglyceride homeostasis (GO:0070328) | 4.34754362 |
| 37 | acylglycerol homeostasis (GO:0055090) | 4.34754362 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.27961420 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.27961420 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.27961420 |
| 41 | plasma lipoprotein particle clearance (GO:0034381) | 4.24601234 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 4.24467641 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.23308099 |
| 44 | positive regulation by symbiont of host defense response (GO:0052509) | 4.22695575 |
| 45 | modulation by symbiont of host defense response (GO:0052031) | 4.22695575 |
| 46 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.22695575 |
| 47 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.22695575 |
| 48 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.22695575 |
| 49 | modulation by symbiont of host immune response (GO:0052553) | 4.22695575 |
| 50 | neutrophil activation involved in immune response (GO:0002283) | 4.18789523 |
| 51 | regulation of cholesterol esterification (GO:0010872) | 4.16397002 |
| 52 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.14020061 |
| 53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.07935316 |
| 54 | lysine metabolic process (GO:0006553) | 4.04871723 |
| 55 | lysine catabolic process (GO:0006554) | 4.04871723 |
| 56 | regulation of interferon-alpha production (GO:0032647) | 4.04316605 |
| 57 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.01989382 |
| 58 | detection of molecule of bacterial origin (GO:0032490) | 4.00653821 |
| 59 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.00200615 |
| 60 | homocysteine metabolic process (GO:0050667) | 3.97909371 |
| 61 | ethanol oxidation (GO:0006069) | 3.92768291 |
| 62 | phospholipid homeostasis (GO:0055091) | 3.90739193 |
| 63 | alpha-amino acid catabolic process (GO:1901606) | 3.90557482 |
| 64 | aromatic amino acid family metabolic process (GO:0009072) | 3.89707841 |
| 65 | bile acid and bile salt transport (GO:0015721) | 3.88701947 |
| 66 | fibrinolysis (GO:0042730) | 3.87774412 |
| 67 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.83867513 |
| 68 | negative regulation of lipase activity (GO:0060192) | 3.83542532 |
| 69 | glutamate metabolic process (GO:0006536) | 3.82526387 |
| 70 | positive regulation of interferon-alpha production (GO:0032727) | 3.81709006 |
| 71 | cholesterol efflux (GO:0033344) | 3.80592448 |
| 72 | immunoglobulin mediated immune response (GO:0016064) | 3.79231248 |
| 73 | positive regulation of lipid catabolic process (GO:0050996) | 3.76850479 |
| 74 | tyrosine metabolic process (GO:0006570) | 3.76368031 |
| 75 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.75064284 |
| 76 | negative regulation of cholesterol transport (GO:0032375) | 3.72048228 |
| 77 | negative regulation of sterol transport (GO:0032372) | 3.72048228 |
| 78 | germinal center formation (GO:0002467) | 3.70089591 |
| 79 | complement activation (GO:0006956) | 3.69744087 |
| 80 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.66172193 |
| 81 | cellular ketone body metabolic process (GO:0046950) | 3.65048601 |
| 82 | complement activation, classical pathway (GO:0006958) | 3.62704532 |
| 83 | cellular amino acid catabolic process (GO:0009063) | 3.61111866 |
| 84 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.60635740 |
| 85 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.59667306 |
| 86 | detection of other organism (GO:0098543) | 3.58118232 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 3.58034031 |
| 88 | benzene-containing compound metabolic process (GO:0042537) | 3.57826285 |
| 89 | protein activation cascade (GO:0072376) | 3.56902278 |
| 90 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.56628971 |
| 91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.56628971 |
| 92 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.56554287 |
| 93 | indolalkylamine metabolic process (GO:0006586) | 3.52491240 |
| 94 | type I interferon signaling pathway (GO:0060337) | 3.52397045 |
| 95 | cellular response to type I interferon (GO:0071357) | 3.52397045 |
| 96 | macrophage activation (GO:0042116) | 3.52016951 |
| 97 | plasma lipoprotein particle assembly (GO:0034377) | 3.51646962 |
| 98 | coenzyme catabolic process (GO:0009109) | 3.50237791 |
| 99 | low-density lipoprotein particle remodeling (GO:0034374) | 3.47850131 |
| 100 | response to type I interferon (GO:0034340) | 3.47369175 |
| 101 | cytolysis (GO:0019835) | 3.47248752 |
| 102 | cellular glucuronidation (GO:0052695) | 3.45419211 |
| 103 | cellular biogenic amine catabolic process (GO:0042402) | 3.44403893 |
| 104 | amine catabolic process (GO:0009310) | 3.44403893 |
| 105 | regulation of cholesterol homeostasis (GO:2000188) | 3.41673811 |
| 106 | microglial cell activation (GO:0001774) | 3.40655265 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.39954841 |
| 108 | positive regulation of type 2 immune response (GO:0002830) | 3.39024715 |
| 109 | fatty acid oxidation (GO:0019395) | 3.39005745 |
| 110 | negative regulation of cell killing (GO:0031342) | 3.38796250 |
| 111 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.38796250 |
| 112 | detection of external biotic stimulus (GO:0098581) | 3.37590809 |
| 113 | 2-oxoglutarate metabolic process (GO:0006103) | 3.37467968 |
| 114 | fatty acid beta-oxidation (GO:0006635) | 3.36325285 |
| 115 | sterol homeostasis (GO:0055092) | 3.35684879 |
| 116 | imidazole-containing compound metabolic process (GO:0052803) | 3.35505813 |
| 117 | acetyl-CoA metabolic process (GO:0006084) | 3.33842900 |
| 118 | short-chain fatty acid metabolic process (GO:0046459) | 3.33400228 |
| 119 | lipid oxidation (GO:0034440) | 3.32453261 |
| 120 | T-helper 1 type immune response (GO:0042088) | 3.32409749 |
| 121 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.31809672 |
| 122 | acute-phase response (GO:0006953) | 3.30979821 |
| 123 | carnitine metabolic process (GO:0009437) | 3.30640786 |
| 124 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.28606278 |
| 125 | organic acid catabolic process (GO:0016054) | 3.27855625 |
| 126 | carboxylic acid catabolic process (GO:0046395) | 3.27855625 |
| 127 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.27557402 |
| 128 | blood coagulation, intrinsic pathway (GO:0007597) | 3.27511594 |
| 129 | negative regulation of protein activation cascade (GO:2000258) | 3.27394779 |
| 130 | monocarboxylic acid catabolic process (GO:0072329) | 3.27149183 |
| 131 | plasma lipoprotein particle organization (GO:0071827) | 3.27117767 |
| 132 | fatty acid transmembrane transport (GO:1902001) | 3.26201511 |
| 133 | defense response to protozoan (GO:0042832) | 3.22804845 |
| 134 | fatty acid catabolic process (GO:0009062) | 3.22712357 |
| 135 | arginine metabolic process (GO:0006525) | 3.22553538 |
| 136 | cellular extravasation (GO:0045123) | 3.22068180 |
| 137 | response to nitrosative stress (GO:0051409) | 3.21268731 |
| 138 | lipoprotein metabolic process (GO:0042157) | 3.20756185 |
| 139 | detection of bacterium (GO:0016045) | 3.20119993 |
| 140 | protein-lipid complex assembly (GO:0065005) | 3.19672911 |
| 141 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.19096838 |
| 142 | response to muramyl dipeptide (GO:0032495) | 3.18880615 |
| 143 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.18236881 |
| 144 | positive regulation of interferon-beta production (GO:0032728) | 3.17527523 |
| 145 | response to protozoan (GO:0001562) | 3.12619097 |
| 146 | granulocyte activation (GO:0036230) | 3.11058198 |
| 147 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.07778501 |
| 148 | myeloid cell activation involved in immune response (GO:0002275) | 3.07169576 |
| 149 | regulation of gamma-delta T cell activation (GO:0046643) | 3.06512765 |
| 150 | neutrophil activation (GO:0042119) | 3.03055779 |
| 151 | detection of biotic stimulus (GO:0009595) | 3.02740152 |
| 152 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.99884297 |
| 153 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.99026303 |
| 154 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.98864905 |
| 155 | response to host immune response (GO:0052572) | 2.98864905 |
| 156 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.96649554 |
| 157 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.94688534 |
| 158 | B cell mediated immunity (GO:0019724) | 2.93303650 |
| 159 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.90579375 |
| 160 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.89117622 |
| 161 | regulation of interleukin-12 production (GO:0032655) | 2.86176079 |
| 162 | regulation of antigen processing and presentation (GO:0002577) | 2.83210147 |
| 163 | regulation of germinal center formation (GO:0002634) | 2.82199990 |
| 164 | regulation of podosome assembly (GO:0071801) | 2.82130196 |
| 165 | positive regulation of interleukin-6 production (GO:0032755) | 2.82076387 |
| 166 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.79864620 |
| 167 | regulation of T-helper cell differentiation (GO:0045622) | 2.78963859 |
| 168 | response to host (GO:0075136) | 2.78895245 |
| 169 | response to host defenses (GO:0052200) | 2.78895245 |
| 170 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.78895245 |
| 171 | regulation of vitamin metabolic process (GO:0030656) | 2.76348881 |
| 172 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.75212834 |
| 173 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.74918391 |
| 174 | regulation of type 2 immune response (GO:0002828) | 2.72914278 |
| 175 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.70991564 |
| 176 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.70726960 |
| 177 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.69814526 |
| 178 | regulation of chemokine biosynthetic process (GO:0045073) | 2.68690121 |
| 179 | negative regulation of T cell mediated immunity (GO:0002710) | 2.68444407 |
| 180 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.68118929 |
| 181 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.67924353 |
| 182 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.65957822 |
| 183 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.65957822 |
| 184 | cellular response to molecule of bacterial origin (GO:0071219) | 2.65869949 |
| 185 | regulation of interferon-beta production (GO:0032648) | 2.65332166 |
| 186 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.65291742 |
| 187 | positive regulation of interleukin-10 production (GO:0032733) | 2.63939334 |
| 188 | cellular response to lipopolysaccharide (GO:0071222) | 2.63653172 |
| 189 | neutrophil mediated immunity (GO:0002446) | 2.63512575 |
| 190 | positive regulation of heat generation (GO:0031652) | 2.63244806 |
| 191 | regulation of tolerance induction (GO:0002643) | 2.63189303 |
| 192 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.62919698 |
| 193 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.62217714 |
| 194 | positive regulation of antigen processing and presentation (GO:0002579) | 2.61087607 |
| 195 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.59506056 |
| 196 | positive regulation of acute inflammatory response (GO:0002675) | 2.58207242 |
| 197 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.56964787 |
| 198 | cellular response to interferon-gamma (GO:0071346) | 2.56920934 |
| 199 | positive regulation of chemokine production (GO:0032722) | 2.55104592 |
| 200 | leukocyte aggregation (GO:0070486) | 2.55031073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.13792967 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.46605336 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.64585245 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.32195234 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.05086594 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.99978374 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.87368972 |
| 8 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.29630544 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.01254758 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.61919564 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.46007379 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.34912182 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.03410345 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.00220064 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.81130605 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.74432262 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.59778127 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.56465617 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.42353949 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11329411 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.09933857 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.01287716 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.95570561 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.80682742 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.76372902 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74563721 |
| 27 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.74500690 |
| 28 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.70818148 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70024933 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68708660 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64866176 |
| 32 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64506611 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63522844 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61453872 |
| 35 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60324257 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59254936 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57134113 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53255309 |
| 39 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50544280 |
| 40 | * MYB_26560356_Chip-Seq_TH2_Human | 1.46925279 |
| 41 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.46597001 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.45848158 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45759816 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.44085337 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36763178 |
| 46 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.35829100 |
| 47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34367199 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30156147 |
| 49 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30003099 |
| 50 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.29804349 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29538995 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28697919 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27205593 |
| 54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26170047 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.21095821 |
| 56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21037460 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20154656 |
| 58 | MYB_26560356_Chip-Seq_TH1_Human | 1.17910362 |
| 59 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17076686 |
| 60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16961312 |
| 61 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.14474724 |
| 62 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.14474724 |
| 63 | MAF_26560356_Chip-Seq_TH1_Human | 1.13752196 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12874532 |
| 65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11591332 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10710704 |
| 67 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10472876 |
| 68 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08387873 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08072449 |
| 70 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07776082 |
| 71 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05550653 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03697583 |
| 73 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00598711 |
| 74 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99699288 |
| 75 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99445866 |
| 76 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98613113 |
| 77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97286053 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96509297 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96469199 |
| 80 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96176275 |
| 81 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93840566 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92738690 |
| 83 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92686476 |
| 84 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91608958 |
| 85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91473209 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91473209 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91001767 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90386835 |
| 89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90002647 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89800418 |
| 91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89084746 |
| 92 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.88513022 |
| 93 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85914404 |
| 94 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85914404 |
| 95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85792791 |
| 96 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85757364 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85486035 |
| 98 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.84114846 |
| 99 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.84085507 |
| 100 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83832203 |
| 101 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83803958 |
| 102 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83677879 |
| 103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83602145 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83105575 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82293185 |
| 106 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81385616 |
| 107 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80582840 |
| 108 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80355264 |
| 109 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80290185 |
| 110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.78815400 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77779535 |
| 112 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.77081162 |
| 113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76644057 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75886925 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74729359 |
| 116 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.74647137 |
| 117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73579439 |
| 118 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72105716 |
| 119 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71978884 |
| 120 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.71780025 |
| 121 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.71723552 |
| 122 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.71404773 |
| 123 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.70716472 |
| 124 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.69682852 |
| 125 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.68578870 |
| 126 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.68065164 |
| 127 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.67455544 |
| 128 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.67263362 |
| 129 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.66989742 |
| 130 | CJUN_26792858_Chip-Seq_BT549_Human | 0.66703659 |
| 131 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.66609182 |
| 132 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66408586 |
| 133 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.66218486 |
| 134 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.66178785 |
| 135 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.65629363 |
| 136 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64484745 |
| 137 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.62538885 |
| 138 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.61298610 |
| 139 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60244751 |
| 140 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59077299 |
| 141 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.58836381 |
| 142 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58429139 |
| 143 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.58177273 |
| 144 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58119356 |
| 145 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.56383310 |
| 146 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56268103 |
| 147 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55583191 |
| 148 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.54772456 |
| 149 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.54361757 |
| 150 | CBP_21632823_ChIP-Seq_H3396_Human | 0.54319828 |
| 151 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.53364890 |
| 152 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.53311785 |
| 153 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.53159284 |
| 154 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.52952380 |
| 155 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52529195 |
| 156 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.52105082 |
| 157 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.52090353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.95578095 |
| 2 | MP0005360_urolithiasis | 6.19359372 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.66402497 |
| 4 | MP0005365_abnormal_bile_salt | 5.40684842 |
| 5 | MP0003303_peritoneal_inflammation | 4.60438295 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.51595416 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.59150888 |
| 8 | MP0003252_abnormal_bile_duct | 3.51897528 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.19717671 |
| 10 | MP0001835_abnormal_antigen_presentation | 3.03756368 |
| 11 | MP0009785_altered_susceptibility_to | 3.00696314 |
| 12 | MP0009840_abnormal_foam_cell | 2.95325413 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.90158567 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.88847453 |
| 15 | MP0005083_abnormal_biliary_tract | 2.69381427 |
| 16 | MP0006082_CNS_inflammation | 2.60490491 |
| 17 | MP0002419_abnormal_innate_immunity | 2.46185246 |
| 18 | MP0003646_muscle_fatigue | 2.43460377 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.37767441 |
| 20 | MP0002332_abnormal_exercise_endurance | 2.34375681 |
| 21 | MP0004510_myositis | 2.31091953 |
| 22 | MP0005025_abnormal_response_to | 2.29075745 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.27018721 |
| 24 | MP0001790_abnormal_immune_system | 2.20549720 |
| 25 | MP0005387_immune_system_phenotype | 2.20549720 |
| 26 | MP0003950_abnormal_plasma_membrane | 2.17918908 |
| 27 | MP0005332_abnormal_amino_acid | 2.17521245 |
| 28 | MP0003195_calcinosis | 2.15072064 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 2.12177629 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 2.10207674 |
| 31 | MP0003011_delayed_dark_adaptation | 2.07317727 |
| 32 | MP0000609_abnormal_liver_physiology | 2.05555859 |
| 33 | MP0001800_abnormal_humoral_immune | 2.03936838 |
| 34 | MP0002452_abnormal_antigen_presenting | 2.02355623 |
| 35 | MP0002723_abnormal_immune_serum | 1.96103802 |
| 36 | MP0002254_reproductive_system_inflammat | 1.88535559 |
| 37 | MP0005671_abnormal_response_to | 1.81963910 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.81958283 |
| 39 | MP0003828_pulmonary_edema | 1.77792760 |
| 40 | MP0008004_abnormal_stomach_pH | 1.75762879 |
| 41 | MP0000685_abnormal_immune_system | 1.73100929 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.72434537 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.66634493 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.66634493 |
| 45 | MP0005319_abnormal_enzyme/_coenzyme | 1.66263480 |
| 46 | MP0002420_abnormal_adaptive_immunity | 1.65823801 |
| 47 | MP0002796_impaired_skin_barrier | 1.65565803 |
| 48 | MP0001819_abnormal_immune_cell | 1.65518076 |
| 49 | MP0004130_abnormal_muscle_cell | 1.63594849 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.62150658 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.53573728 |
| 52 | MP0001853_heart_inflammation | 1.53356692 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.52347708 |
| 54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51262325 |
| 55 | MP0005670_abnormal_white_adipose | 1.50275540 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 1.48912583 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.47921288 |
| 58 | MP0000343_altered_response_to | 1.46143993 |
| 59 | MP0002405_respiratory_system_inflammati | 1.42149049 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.38916681 |
| 61 | MP0003868_abnormal_feces_composition | 1.36673807 |
| 62 | MP0001764_abnormal_homeostasis | 1.35891925 |
| 63 | MP0005647_abnormal_sex_gland | 1.33304370 |
| 64 | MP0009278_abnormal_bone_marrow | 1.30157549 |
| 65 | MP0005451_abnormal_body_composition | 1.29515978 |
| 66 | MP0005164_abnormal_response_to | 1.28724562 |
| 67 | MP0004484_altered_response_of | 1.27538565 |
| 68 | MP0003448_altered_tumor_morphology | 1.26979983 |
| 69 | MP0000749_muscle_degeneration | 1.25721447 |
| 70 | MP0003045_fibrosis | 1.23073543 |
| 71 | MP0004883_abnormal_blood_vessel | 1.22395045 |
| 72 | MP0005310_abnormal_salivary_gland | 1.21381893 |
| 73 | MP0002998_abnormal_bone_remodeling | 1.20750545 |
| 74 | MP0006054_spinal_hemorrhage | 1.20715980 |
| 75 | MP0000716_abnormal_immune_system | 1.16520681 |
| 76 | MP0009697_abnormal_copulation | 1.15833431 |
| 77 | MP0008260_abnormal_autophagy | 1.15416197 |
| 78 | MP0005666_abnormal_adipose_tissue | 1.14541990 |
| 79 | MP0000858_altered_metastatic_potential | 1.13294131 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.12825267 |
| 81 | MP0009643_abnormal_urine_homeostasis | 1.10254135 |
| 82 | MP0009764_decreased_sensitivity_to | 1.10045353 |
| 83 | MP0002971_abnormal_brown_adipose | 1.09090468 |
| 84 | MP0003763_abnormal_thymus_physiology | 1.07830758 |
| 85 | MP0000604_amyloidosis | 1.04935339 |
| 86 | MP0003172_abnormal_lysosome_physiology | 1.04622608 |
| 87 | MP0002398_abnormal_bone_marrow | 1.04285971 |
| 88 | MP0000598_abnormal_liver_morphology | 1.02939461 |
| 89 | MP0002006_tumorigenesis | 1.01722918 |
| 90 | MP0010352_gastrointestinal_tract_polyps | 1.00707066 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 1.00310808 |
| 92 | MP0009763_increased_sensitivity_to | 1.00131127 |
| 93 | MP0003091_abnormal_cell_migration | 0.98801059 |
| 94 | MP0002837_dystrophic_cardiac_calcinosis | 0.96932103 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.95206213 |
| 96 | MP0004036_abnormal_muscle_relaxation | 0.95022931 |
| 97 | MP0004381_abnormal_hair_follicle | 0.94277125 |
| 98 | MP0005334_abnormal_fat_pad | 0.92532918 |
| 99 | MP0005023_abnormal_wound_healing | 0.92319967 |
| 100 | MP0004185_abnormal_adipocyte_glucose | 0.92190021 |
| 101 | MP0003724_increased_susceptibility_to | 0.92058281 |
| 102 | MP0003690_abnormal_glial_cell | 0.91943387 |
| 103 | MP0003186_abnormal_redox_activity | 0.91449631 |
| 104 | MP0009333_abnormal_splenocyte_physiolog | 0.89480016 |
| 105 | MP0004782_abnormal_surfactant_physiolog | 0.88776333 |
| 106 | MP0000689_abnormal_spleen_morphology | 0.88745519 |
| 107 | MP0005165_increased_susceptibility_to | 0.88655234 |
| 108 | MP0008469_abnormal_protein_level | 0.86984867 |
| 109 | MP0002060_abnormal_skin_morphology | 0.85390045 |
| 110 | MP0000569_abnormal_digit_pigmentation | 0.84950582 |
| 111 | MP0002429_abnormal_blood_cell | 0.84924687 |
| 112 | MP0000579_abnormal_nail_morphology | 0.84140731 |
| 113 | MP0004233_abnormal_muscle_weight | 0.82324314 |
| 114 | MP0002722_abnormal_immune_system | 0.80529229 |
| 115 | MP0009642_abnormal_blood_homeostasis | 0.78005272 |
| 116 | MP0002277_abnormal_respiratory_mucosa | 0.77520996 |
| 117 | MP0005084_abnormal_gallbladder_morpholo | 0.76140892 |
| 118 | MP0005464_abnormal_platelet_physiology | 0.74052595 |
| 119 | MP0003436_decreased_susceptibility_to | 0.73902493 |
| 120 | MP0002078_abnormal_glucose_homeostasis | 0.73830741 |
| 121 | MP0005535_abnormal_body_temperature | 0.73569267 |
| 122 | MP0002972_abnormal_cardiac_muscle | 0.72367129 |
| 123 | MP0005636_abnormal_mineral_homeostasis | 0.72149281 |
| 124 | MP0005275_abnormal_skin_tensile | 0.71745955 |
| 125 | MP0003075_altered_response_to | 0.71639731 |
| 126 | MP0000750_abnormal_muscle_regeneration | 0.69891849 |
| 127 | MP0003453_abnormal_keratinocyte_physiol | 0.69599422 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.69535873 |
| 129 | MP0005058_abnormal_lysosome_morphology | 0.68854683 |
| 130 | MP0000015_abnormal_ear_pigmentation | 0.67844577 |
| 131 | MP0001879_abnormal_lymphatic_vessel | 0.67000064 |
| 132 | MP0004084_abnormal_cardiac_muscle | 0.66612294 |
| 133 | MP0004808_abnormal_hematopoietic_stem | 0.66503224 |
| 134 | MP0004947_skin_inflammation | 0.65965428 |
| 135 | MP0005501_abnormal_skin_physiology | 0.65855067 |
| 136 | MP0006036_abnormal_mitochondrial_physio | 0.65529499 |
| 137 | MP0000427_abnormal_hair_cycle | 0.65352887 |
| 138 | MP0000371_diluted_coat_color | 0.65256265 |
| 139 | MP0005390_skeleton_phenotype | 0.63985385 |
| 140 | MP0000372_irregular_coat_pigmentation | 0.63308862 |
| 141 | MP0001216_abnormal_epidermal_layer | 0.62088629 |
| 142 | MP0005166_decreased_susceptibility_to | 0.61763129 |
| 143 | MP0003638_abnormal_response/metabolism_ | 0.61756296 |
| 144 | MP0009115_abnormal_fat_cell | 0.61352953 |
| 145 | MP0005408_hypopigmentation | 0.60602192 |
| 146 | MP0001881_abnormal_mammary_gland | 0.60566264 |
| 147 | MP0009765_abnormal_xenobiotic_induced | 0.60011688 |
| 148 | MP0003300_gastrointestinal_ulcer | 0.59194982 |
| 149 | MP0001756_abnormal_urination | 0.59033441 |
| 150 | MP0009384_cardiac_valve_regurgitation | 0.58975551 |
| 151 | MP0003566_abnormal_cell_adhesion | 0.57525050 |
| 152 | MP0005375_adipose_tissue_phenotype | 0.57196511 |
| 153 | MP0002090_abnormal_vision | 0.57136883 |
| 154 | MP0000249_abnormal_blood_vessel | 0.56838587 |
| 155 | MP0002098_abnormal_vibrissa_morphology | 0.55837769 |
| 156 | MP0005448_abnormal_energy_balance | 0.55330101 |
| 157 | MP0000647_abnormal_sebaceous_gland | 0.55205698 |
| 158 | MP0002928_abnormal_bile_duct | 0.55169811 |
| 159 | MP0001661_extended_life_span | 0.53951258 |
| 160 | MP0008874_decreased_physiological_sensi | 0.53793181 |
| 161 | MP0002166_altered_tumor_susceptibility | 0.52836641 |
| 162 | MP0005410_abnormal_fertilization | 0.50122867 |
| 163 | MP0002876_abnormal_thyroid_physiology | 0.49733717 |
| 164 | MP0002136_abnormal_kidney_physiology | 0.48679095 |
| 165 | MP0005266_abnormal_metabolism | 0.46840532 |
| 166 | MP0006138_congestive_heart_failure | 0.46618153 |
| 167 | MP0000377_abnormal_hair_follicle | 0.46617699 |
| 168 | MP0000230_abnormal_systemic_arterial | 0.46353363 |
| 169 | MP0004147_increased_porphyrin_level | 0.45407201 |
| 170 | MP0001851_eye_inflammation | 0.44658055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.87144801 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.34593865 |
| 3 | Complement deficiency (HP:0004431) | 6.13946611 |
| 4 | Xanthomatosis (HP:0000991) | 5.72675731 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.68578747 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.53057268 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.39913038 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.26068018 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.93693645 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.81110065 |
| 11 | Optic neuritis (HP:0100653) | 4.74485057 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.74485057 |
| 13 | Orchitis (HP:0100796) | 4.68307404 |
| 14 | Abnormality of complement system (HP:0005339) | 4.58090340 |
| 15 | Nemaline bodies (HP:0003798) | 4.57499875 |
| 16 | Joint hemorrhage (HP:0005261) | 4.47053847 |
| 17 | Muscle fiber inclusion bodies (HP:0100299) | 4.41229122 |
| 18 | Myositis (HP:0100614) | 4.37944481 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.36443386 |
| 20 | Eczematoid dermatitis (HP:0000976) | 4.36358106 |
| 21 | Epidermoid cyst (HP:0200040) | 4.35312268 |
| 22 | Recurrent abscess formation (HP:0002722) | 4.30790586 |
| 23 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.29630024 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 4.23980602 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 4.17338288 |
| 26 | Stomatitis (HP:0010280) | 4.08937760 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.06787734 |
| 28 | Hyperammonemia (HP:0001987) | 4.01162385 |
| 29 | Abnormality of macrophages (HP:0004311) | 3.97806374 |
| 30 | Ketosis (HP:0001946) | 3.81152267 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.77040908 |
| 32 | Hyperglycinemia (HP:0002154) | 3.71228408 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 3.68296641 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.68296641 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.68296641 |
| 36 | Keratoconjunctivitis sicca (HP:0001097) | 3.66613068 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 3.66010147 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.61027626 |
| 39 | Fat malabsorption (HP:0002630) | 3.57473473 |
| 40 | Hyperglycinuria (HP:0003108) | 3.48602273 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.47409368 |
| 42 | Abnormality of the intrinsic pathway (HP:0010989) | 3.45031634 |
| 43 | Keratoconjunctivitis (HP:0001096) | 3.40442880 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.35778815 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 3.35778815 |
| 46 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.28380102 |
| 47 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.27416265 |
| 48 | Myocardial infarction (HP:0001658) | 3.21476229 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 3.14986800 |
| 50 | Muscle fiber splitting (HP:0003555) | 3.14796133 |
| 51 | Abnormality of methionine metabolism (HP:0010901) | 3.13748461 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.11366754 |
| 53 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.00234758 |
| 54 | Glomerulonephritis (HP:0000099) | 2.97803760 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.95998524 |
| 56 | Recurrent skin infections (HP:0001581) | 2.94014939 |
| 57 | Hematochezia (HP:0002573) | 2.93792744 |
| 58 | Gangrene (HP:0100758) | 2.92391579 |
| 59 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.88070239 |
| 60 | Esophageal varix (HP:0002040) | 2.87730312 |
| 61 | Cholecystitis (HP:0001082) | 2.87291300 |
| 62 | Abnormal gallbladder physiology (HP:0012438) | 2.87291300 |
| 63 | Conjugated hyperbilirubinemia (HP:0002908) | 2.86139846 |
| 64 | Spontaneous abortion (HP:0005268) | 2.85509169 |
| 65 | Spontaneous hematomas (HP:0007420) | 2.83422671 |
| 66 | Ketoacidosis (HP:0001993) | 2.78266723 |
| 67 | Thick nail (HP:0001805) | 2.75836396 |
| 68 | Hepatocellular carcinoma (HP:0001402) | 2.74233305 |
| 69 | Hemoptysis (HP:0002105) | 2.74047809 |
| 70 | Asymmetric septal hypertrophy (HP:0001670) | 2.73431588 |
| 71 | Vasculitis (HP:0002633) | 2.70698305 |
| 72 | Skin nodule (HP:0200036) | 2.69869695 |
| 73 | Steatorrhea (HP:0002570) | 2.68691432 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 2.68597479 |
| 75 | Hyperbilirubinemia (HP:0002904) | 2.67166113 |
| 76 | Arterial thrombosis (HP:0004420) | 2.66407544 |
| 77 | Increased IgE level (HP:0003212) | 2.65686693 |
| 78 | Amyloidosis (HP:0011034) | 2.65444796 |
| 79 | Cholelithiasis (HP:0001081) | 2.65422599 |
| 80 | Vascular calcification (HP:0004934) | 2.63143293 |
| 81 | Recurrent fungal infections (HP:0002841) | 2.62617469 |
| 82 | Pulmonary infiltrates (HP:0002113) | 2.60440748 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 2.58012258 |
| 84 | Abnormality of purine metabolism (HP:0004352) | 2.54932447 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 2.54602257 |
| 86 | Exercise-induced muscle cramps (HP:0003710) | 2.53842532 |
| 87 | Abnormality of nucleobase metabolism (HP:0010932) | 2.53689038 |
| 88 | Distal lower limb muscle weakness (HP:0009053) | 2.51621173 |
| 89 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.51202220 |
| 90 | Increased serum ferritin (HP:0003281) | 2.46847999 |
| 91 | Type 1 muscle fiber predominance (HP:0003803) | 2.45956737 |
| 92 | Loss of speech (HP:0002371) | 2.45827032 |
| 93 | Hemorrhage of the eye (HP:0011885) | 2.44829991 |
| 94 | Disinhibition (HP:0000734) | 2.44538629 |
| 95 | Delayed CNS myelination (HP:0002188) | 2.42525312 |
| 96 | Hypoglycemic seizures (HP:0002173) | 2.38800375 |
| 97 | Nephritis (HP:0000123) | 2.37491314 |
| 98 | Gingivitis (HP:0000230) | 2.37392694 |
| 99 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.35519708 |
| 100 | Chest pain (HP:0100749) | 2.34985613 |
| 101 | Cardiovascular calcification (HP:0011915) | 2.33672199 |
| 102 | Autoimmune thrombocytopenia (HP:0001973) | 2.32055439 |
| 103 | Meningitis (HP:0001287) | 2.30931574 |
| 104 | T lymphocytopenia (HP:0005403) | 2.28875485 |
| 105 | Autoimmune hemolytic anemia (HP:0001890) | 2.28612935 |
| 106 | Urticaria (HP:0001025) | 2.27673335 |
| 107 | Metabolic acidosis (HP:0001942) | 2.27326978 |
| 108 | Frequent falls (HP:0002359) | 2.26402074 |
| 109 | Abnormality of serum amino acid levels (HP:0003112) | 2.24893507 |
| 110 | Mitral stenosis (HP:0001718) | 2.24870508 |
| 111 | Polyneuropathy (HP:0001271) | 2.24848737 |
| 112 | Abnormality of T cell number (HP:0011839) | 2.23394860 |
| 113 | Obstructive lung disease (HP:0006536) | 2.23348328 |
| 114 | Chronic obstructive pulmonary disease (HP:0006510) | 2.23348328 |
| 115 | Right ventricular cardiomyopathy (HP:0011663) | 2.23018995 |
| 116 | Recurrent viral infections (HP:0004429) | 2.21592030 |
| 117 | Interstitial pulmonary disease (HP:0006530) | 2.21474883 |
| 118 | Hypochromic microcytic anemia (HP:0004840) | 2.21403761 |
| 119 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.21080335 |
| 120 | Dicarboxylic aciduria (HP:0003215) | 2.21080335 |
| 121 | Acanthocytosis (HP:0001927) | 2.20790575 |
| 122 | Vacuolated lymphocytes (HP:0001922) | 2.20419734 |
| 123 | EMG: myopathic abnormalities (HP:0003458) | 2.19590386 |
| 124 | Gout (HP:0001997) | 2.18470855 |
| 125 | Spastic diplegia (HP:0001264) | 2.18352880 |
| 126 | Neonatal onset (HP:0003623) | 2.17409723 |
| 127 | Malnutrition (HP:0004395) | 2.17305024 |
| 128 | Menorrhagia (HP:0000132) | 2.16779539 |
| 129 | Encephalitis (HP:0002383) | 2.16652178 |
| 130 | Episodic fever (HP:0001954) | 2.16647805 |
| 131 | Difficulty running (HP:0009046) | 2.14971857 |
| 132 | Calf muscle hypertrophy (HP:0008981) | 2.11851983 |
| 133 | Pigmentary retinal degeneration (HP:0001146) | 2.11424680 |
| 134 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.10143651 |
| 135 | Recurrent cutaneous fungal infections (HP:0011370) | 2.10143651 |
| 136 | Gingival bleeding (HP:0000225) | 2.10137154 |
| 137 | Dysostosis multiplex (HP:0000943) | 2.10015632 |
| 138 | Prolonged bleeding time (HP:0003010) | 2.09745733 |
| 139 | Anorexia (HP:0002039) | 2.07656556 |
| 140 | Vertigo (HP:0002321) | 2.07375723 |
| 141 | Malignant hyperthermia (HP:0002047) | 2.06646570 |
| 142 | Sensorimotor neuropathy (HP:0007141) | 2.05665955 |
| 143 | Abnormality of the gallbladder (HP:0005264) | 2.04258728 |
| 144 | Leukocytosis (HP:0001974) | 2.03201128 |
| 145 | Neck muscle weakness (HP:0000467) | 2.02971594 |
| 146 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02417838 |
| 147 | Lethargy (HP:0001254) | 2.01999575 |
| 148 | Thrombophlebitis (HP:0004418) | 2.01872233 |
| 149 | Petechiae (HP:0000967) | 1.98522910 |
| 150 | Upper motor neuron abnormality (HP:0002127) | 1.97706064 |
| 151 | Polycythemia (HP:0001901) | 1.96876231 |
| 152 | Hypertriglyceridemia (HP:0002155) | 1.96117693 |
| 153 | Stroke (HP:0001297) | 1.95860047 |
| 154 | Basal ganglia calcification (HP:0002135) | 1.95671404 |
| 155 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95537438 |
| 156 | Pancreatitis (HP:0001733) | 1.94205193 |
| 157 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.92183541 |
| 158 | Distal arthrogryposis (HP:0005684) | 1.91886647 |
| 159 | Myoglobinuria (HP:0002913) | 1.91775641 |
| 160 | Parakeratosis (HP:0001036) | 1.91653059 |
| 161 | Epistaxis (HP:0000421) | 1.91353743 |
| 162 | Abnormality of the endocardium (HP:0004306) | 1.89689310 |
| 163 | Abnormality of the pleura (HP:0002103) | 1.88119418 |
| 164 | Late onset (HP:0003584) | 1.86747117 |
| 165 | Hydroxyprolinuria (HP:0003080) | 1.86482439 |
| 166 | Abnormality of proline metabolism (HP:0010907) | 1.86482439 |
| 167 | Hyporeflexia of lower limbs (HP:0002600) | 1.85934672 |
| 168 | Keratitis (HP:0000491) | 1.84195367 |
| 169 | Abnormality of iron homeostasis (HP:0011031) | 1.83912083 |
| 170 | Hypergammaglobulinemia (HP:0010702) | 1.82960316 |
| 171 | Subaortic stenosis (HP:0001682) | 1.82780368 |
| 172 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.82780368 |
| 173 | Irritability (HP:0000737) | 1.80741570 |
| 174 | Bulbar palsy (HP:0001283) | 1.79529306 |
| 175 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78375917 |
| 176 | Osteomyelitis (HP:0002754) | 1.78193337 |
| 177 | Exercise-induced myalgia (HP:0003738) | 1.77791262 |
| 178 | Popliteal pterygium (HP:0009756) | 1.76718627 |
| 179 | Abnormality of the neuromuscular junction (HP:0003398) | 1.76655456 |
| 180 | Fatigable weakness (HP:0003473) | 1.76655456 |
| 181 | Abnormality of the Achilles tendon (HP:0005109) | 1.76348124 |
| 182 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.74722665 |
| 183 | Axonal loss (HP:0003447) | 1.72844889 |
| 184 | Vomiting (HP:0002013) | 1.71669594 |
| 185 | Cerebral edema (HP:0002181) | 1.71158365 |
| 186 | Poikilocytosis (HP:0004447) | 1.68375420 |
| 187 | Pulmonary embolism (HP:0002204) | 1.66919265 |
| 188 | Acanthosis nigricans (HP:0000956) | 1.64016319 |
| 189 | Brushfield spots (HP:0001088) | 1.63320158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.93762838 |
| 2 | ERN1 | 3.56532145 |
| 3 | SIK1 | 3.25161095 |
| 4 | BLK | 2.88670471 |
| 5 | RIPK4 | 2.75337884 |
| 6 | FGFR4 | 2.69519390 |
| 7 | MST1R | 2.60877127 |
| 8 | IRAK4 | 2.54668728 |
| 9 | TRIB3 | 2.44947923 |
| 10 | BMPR2 | 2.34345909 |
| 11 | TGFBR2 | 2.23990248 |
| 12 | TAOK3 | 2.23223519 |
| 13 | TIE1 | 2.21574009 |
| 14 | INSRR | 2.11178517 |
| 15 | IKBKB | 2.08644953 |
| 16 | PDK3 | 2.07023884 |
| 17 | PDK4 | 2.07023884 |
| 18 | RIPK1 | 2.00688674 |
| 19 | JAK3 | 1.91704944 |
| 20 | FGR | 1.91303627 |
| 21 | PKN2 | 1.88944316 |
| 22 | GRK7 | 1.87879207 |
| 23 | MAP3K13 | 1.86035857 |
| 24 | MATK | 1.84494135 |
| 25 | PTK6 | 1.81634667 |
| 26 | MAP4K1 | 1.76797314 |
| 27 | PIK3CG | 1.76474825 |
| 28 | CAMK1D | 1.74752201 |
| 29 | PDK2 | 1.74736435 |
| 30 | MAP2K4 | 1.71040966 |
| 31 | ERBB4 | 1.61685186 |
| 32 | DAPK2 | 1.59655933 |
| 33 | TYK2 | 1.50828502 |
| 34 | TTN | 1.49770492 |
| 35 | FRK | 1.49024499 |
| 36 | MAP3K3 | 1.49003877 |
| 37 | NEK9 | 1.48792324 |
| 38 | IRAK1 | 1.47272601 |
| 39 | LATS1 | 1.46925563 |
| 40 | ZAP70 | 1.45144398 |
| 41 | MAP2K3 | 1.35321396 |
| 42 | MOS | 1.34388547 |
| 43 | TXK | 1.34224231 |
| 44 | FES | 1.33096570 |
| 45 | MAPK11 | 1.33021020 |
| 46 | TAOK2 | 1.31251278 |
| 47 | PRKAA2 | 1.31226813 |
| 48 | MAP3K14 | 1.28440547 |
| 49 | CAMK1G | 1.28052337 |
| 50 | KDR | 1.26528591 |
| 51 | JAK1 | 1.21673520 |
| 52 | MAPKAPK3 | 1.21364122 |
| 53 | MYLK | 1.15003778 |
| 54 | DDR2 | 1.14007815 |
| 55 | SYK | 1.11910259 |
| 56 | TAOK1 | 1.11273513 |
| 57 | GRK1 | 1.08385880 |
| 58 | FGFR2 | 1.08299404 |
| 59 | MAPK12 | 1.07901914 |
| 60 | JAK2 | 1.07473350 |
| 61 | MAP3K7 | 1.07272166 |
| 62 | CHUK | 1.06750193 |
| 63 | BTK | 1.05869388 |
| 64 | IRAK2 | 1.05329803 |
| 65 | STK10 | 1.01251784 |
| 66 | LYN | 1.00541917 |
| 67 | HCK | 1.00183909 |
| 68 | MST4 | 0.98647136 |
| 69 | FER | 0.98540757 |
| 70 | PRPF4B | 0.98228733 |
| 71 | TBK1 | 0.98175225 |
| 72 | TEC | 0.97915366 |
| 73 | CDK6 | 0.97450002 |
| 74 | FGFR3 | 0.96318491 |
| 75 | MAPK15 | 0.95576587 |
| 76 | MARK3 | 0.93574250 |
| 77 | KIT | 0.92335162 |
| 78 | EPHB1 | 0.92135214 |
| 79 | OBSCN | 0.91918287 |
| 80 | STK38 | 0.88897409 |
| 81 | SGK3 | 0.87953432 |
| 82 | FLT3 | 0.86738691 |
| 83 | MAP3K12 | 0.85864997 |
| 84 | SIK3 | 0.85405867 |
| 85 | EIF2AK3 | 0.83693617 |
| 86 | IRAK3 | 0.79322991 |
| 87 | TNK2 | 0.78899080 |
| 88 | ACVR1B | 0.75656973 |
| 89 | PTK2B | 0.74847619 |
| 90 | LCK | 0.74729815 |
| 91 | GSK3A | 0.73258922 |
| 92 | PDPK1 | 0.71338489 |
| 93 | MAPK4 | 0.70222848 |
| 94 | CSK | 0.69995613 |
| 95 | PIK3CA | 0.69059574 |
| 96 | ICK | 0.69021138 |
| 97 | CDC42BPA | 0.68682654 |
| 98 | ERBB2 | 0.67903001 |
| 99 | MET | 0.66207963 |
| 100 | MAP2K6 | 0.65982484 |
| 101 | SGK2 | 0.65359693 |
| 102 | PRKAA1 | 0.65182895 |
| 103 | CSF1R | 0.64740647 |
| 104 | PINK1 | 0.63929944 |
| 105 | DYRK1B | 0.62935481 |
| 106 | MAP3K2 | 0.62823103 |
| 107 | PDK1 | 0.62062833 |
| 108 | PHKG1 | 0.61364151 |
| 109 | PHKG2 | 0.61364151 |
| 110 | PRKACG | 0.59727717 |
| 111 | ABL2 | 0.58621119 |
| 112 | MAP3K6 | 0.58025658 |
| 113 | PIM1 | 0.57366033 |
| 114 | MAP2K1 | 0.56365605 |
| 115 | ITK | 0.55721346 |
| 116 | ABL1 | 0.55471527 |
| 117 | STK38L | 0.55422852 |
| 118 | LRRK2 | 0.54897128 |
| 119 | STK3 | 0.54695157 |
| 120 | TRPM7 | 0.54579925 |
| 121 | BMX | 0.54473190 |
| 122 | MUSK | 0.54207019 |
| 123 | PRKCZ | 0.53287391 |
| 124 | NME2 | 0.52899005 |
| 125 | AKT3 | 0.52620250 |
| 126 | GRK6 | 0.51719618 |
| 127 | IKBKE | 0.51461815 |
| 128 | STK24 | 0.50287961 |
| 129 | EPHA3 | 0.49508136 |
| 130 | IGF1R | 0.48346304 |
| 131 | PIM2 | 0.47753840 |
| 132 | NLK | 0.47738269 |
| 133 | RET | 0.47086366 |
| 134 | PTK2 | 0.46247106 |
| 135 | EPHB2 | 0.46234586 |
| 136 | EGFR | 0.46094801 |
| 137 | CAMKK1 | 0.46054398 |
| 138 | MAPK7 | 0.44830791 |
| 139 | LMTK2 | 0.43470505 |
| 140 | PRKD1 | 0.42491675 |
| 141 | CAMK2G | 0.41891105 |
| 142 | PRKCH | 0.41463678 |
| 143 | MAP3K1 | 0.40984630 |
| 144 | ADRBK2 | 0.40945455 |
| 145 | MAP3K5 | 0.34914079 |
| 146 | EEF2K | 0.33018235 |
| 147 | MAP3K11 | 0.32171505 |
| 148 | SGK223 | 0.32115690 |
| 149 | MARK2 | 0.30148266 |
| 150 | OXSR1 | 0.28070521 |
| 151 | MAPKAPK2 | 0.26996749 |
| 152 | KSR2 | 0.26982726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.29799882 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.00894110 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.42106208 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.02096729 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.98013276 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.90567917 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.87400501 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.73116033 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.72257323 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61028090 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.56694444 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45688952 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.44350904 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.43877809 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 2.41996726 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.40840230 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 2.39118930 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.33362838 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 2.28335549 |
| 20 | Malaria_Homo sapiens_hsa05144 | 2.28111847 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.25555520 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.24310078 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23828676 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.21045367 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.13650604 |
| 26 | Asthma_Homo sapiens_hsa05310 | 2.13419773 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.11651702 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10490384 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.04133647 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.03371771 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.98357226 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.97717573 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.97445929 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.96919610 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.95911100 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.93285113 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87857922 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.87617667 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.81913574 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80052787 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.75609823 |
| 42 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70995882 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69386558 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69334300 |
| 45 | Measles_Homo sapiens_hsa05162 | 1.67783293 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67114067 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.63445435 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.62098810 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61161239 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.59351452 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59055087 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 1.57571520 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57385373 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.54813397 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.53131271 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.52822268 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 1.43054785 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42620923 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41350865 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 1.40521974 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 1.38849134 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35374783 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33350215 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32677853 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30280974 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28310062 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.27575320 |
| 68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26536049 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24316319 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23398420 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.22171258 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.21324631 |
| 73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18445081 |
| 74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17239374 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16911797 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 1.15519936 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.12763119 |
| 78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11089855 |
| 79 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.08199188 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.07441008 |
| 81 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05160851 |
| 82 | Hepatitis B_Homo sapiens_hsa05161 | 1.04197865 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03972582 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03054992 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02776820 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02578930 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99804108 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97739362 |
| 89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94242048 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.92205696 |
| 91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90236325 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.88434909 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86934298 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86276923 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83061915 |
| 96 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79634761 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.79463058 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79130552 |
| 99 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.79102944 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.78180447 |
| 101 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.78110976 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77074661 |
| 103 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.71704416 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.70684238 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69312341 |
| 106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65462360 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65357077 |
| 108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.62401402 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61909151 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61273116 |
| 111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59885724 |
| 112 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59806544 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59733134 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58876096 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58495435 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58404305 |
| 117 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.58010642 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57004071 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.56156243 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56127094 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55687256 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55141444 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52873723 |
| 124 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52846411 |
| 125 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51238631 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50809384 |
| 127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49635424 |
| 128 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49482263 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46530843 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45884428 |
| 131 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44530461 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43288740 |
| 133 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43144887 |
| 134 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40715523 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39767180 |
| 136 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39602748 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.39075897 |
| 138 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38439800 |
| 139 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37410005 |
| 140 | Endocytosis_Homo sapiens_hsa04144 | 0.34246638 |
| 141 | Prostate cancer_Homo sapiens_hsa05215 | 0.33836364 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32599829 |
| 143 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31370862 |
| 144 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30937740 |
| 145 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29968692 |
| 146 | Mineral absorption_Homo sapiens_hsa04978 | 0.29512775 |
| 147 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29377888 |
| 148 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29354942 |
| 149 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29309162 |
| 150 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28948751 |
| 151 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27934785 |
| 152 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27242173 |
| 153 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26135304 |
| 154 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.24860627 |
| 155 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24737712 |
| 156 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22380339 |
| 157 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22220356 |
| 158 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.22113860 |
| 159 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.12013831 |
| 160 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.10820309 |
| 161 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.07778374 |
| 162 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.07679568 |
| 163 | Lysosome_Homo sapiens_hsa04142 | 0.06316099 |
| 164 | Amoebiasis_Homo sapiens_hsa05146 | 0.05976658 |
| 165 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.01173362 |
| 166 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1155560 |
| 167 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1060653 |
| 168 | Adherens junction_Homo sapiens_hsa04520 | -0.0954304 |
| 169 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0900105 |
| 170 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0892724 |
| 171 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0860772 |
| 172 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0819149 |
| 173 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0732080 |
| 174 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0694757 |
| 175 | Hepatitis C_Homo sapiens_hsa05160 | -0.0678057 |
| 176 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0648885 |
| 177 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0502239 |
| 178 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0493418 |
| 179 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0110932 |
| 180 | Pertussis_Homo sapiens_hsa05133 | -0.0078703 |

